| Sumiko Ts'kamura, MD | |
|
503 Bowman Gray Dr Ste A, Greenville, NC 27834-7286 | |
| (252) 830-2728 | |
| (252) 752-8288 |
| Full Name | Sumiko Ts'kamura |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Location | 503 Bowman Gray Dr Ste A, Greenville, North Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033207428 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 18775 (North Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sumiko Ts'kamura, MD 419 Lee St, Greenville, NC 27858-8658 Ph: (252) 355-5396 | Sumiko Ts'kamura, MD 503 Bowman Gray Dr Ste A, Greenville, NC 27834-7286 Ph: (252) 830-2728 |
News Archive
Stem cell research published today offers up new clues as to how Parkinson's spreads from cell to cell, a process which has evaded researchers for decades.
Inova Labs, Inc. of Austin, Texas announced today the closing of the private placement of shares of its Series A Preferred Stock. The placement went to investment funds affiliated with Three Arch Partners, based in Silicon Valley, California. Inova received gross proceeds of $10.0 million from the equity financing, which will be used for nationwide and international sales expansion of its LifeChoice® portable oxygen concentrator product line, continuation of next stage developments, and working capital.
MICARDIS(R) (telmisartan) has received Health Canada approval to reduce the risk of non-fatal stroke or non-fatal myocardial infarction in patients 55 years or older at high risk of developing major cardiovascular events who cannot tolerate an angiotensin converting enzyme (ACE) inhibitor.
Neurotech SA announced positive results from an open-label Phase I clinical trial (03-EI-0234) of its lead product, NT-501. NT-501 uses Neurotech's patented Encapsulated Cell Technology (ECT) as a device to deliver ciliary neurotrophic factor (CNTF) to eyes of visually impaired patients with retinitis pigmentosa (RP). Neurotech is a biotechnology company specializing in the development of novel therapeutics to treat diseases of the eye. The company is headquartered in Paris.
What creates that irresistible urge for a bag of potato chips or a hunk of chocolate cake, as opposed to a nice crisp apple? Can food urges be irresistible?
› Verified 9 days ago
Dr. John N Catanzaro, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 115 Heart Dr, Greenville, NC 27834 Phone: 252-744-4400 Fax: 252-744-3987 | |
Ms. Kimberly Michelle Biichle, M.D Internal Medicine Medicare: Medicare Enrolled Practice Location: 1400 Sullivan Dr, Greenville, NC 27834 Phone: 252-931-5686 | |
Jennifer Beth Emberger, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2390 Hemby Ln, Greenville, NC 27834 Phone: 252-744-4500 Fax: 252-744-5713 | |
Dr. Edward L Treadwell, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 600 Moye Blvd, Greenville, NC 27834 Phone: 252-744-3169 Fax: 252-744-3725 | |
Dr. Alpesh Patel, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2210 Hemby Ln, Greenville, NC 27834 Phone: 252-551-3000 Fax: 252-551-3100 | |
Dr. Kara Anne Regan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 521 Moye Blvd Ste C3, Greenville, NC 27834 Phone: 252-816-0800 | |
Radhamani Kannaiyan, M.D., Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2100 Stantonsburg Rd, Greenville, NC 27834 Phone: 520-548-7894 |